The effect of quinolinate on rat brain lipid peroxidation is dependent on iron

Neurochem Int. 1997 Feb;30(2):233-7.

Abstract

Quinolinate, an endogenous excitotoxic metabolite of tryptophan with affinity to the N-methyl-D-aspartate type of glutamate receptor, is known as a stimulator of lipid peroxidation in vitro [Neurochem. Res. (1991) 16, 1139-1143]. To analyse the mechanism of this quinolinate toxicity we used the thiobarbituric acid test to measure malondialdehyde in homogenates of rat cerebral hemispheres incubated in air at 37 degrees C for 30 min in the presence of 0.015-15.0 mM quinolinate, endogenous iron or 0.5-2.0 microM FeSO4 and with or without 250 microM ascorbate. Quinolinate in the concentrations of 0.15-2.5 mM stimulated lipid peroxidation in the homogenates in the presence of 0.5-2.0 microM Fe2+. However, quinolinate concentrations higher than 3.0 mM inhibited the lipid peroxidation at all the tested concentrations of iron. In the presence of a potent iron chelator (10 microM deferoxamine) quinolinate completely failed to induce lipid peroxidation in rat brain homogenates. Spectral analysis revealed that quinolinate is able to form a complex with Fe2+. The results suggest that quinolinate does not have a direct peroxidative effect, but that it modulates lipid peroxidation via its interaction with iron.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ascorbic Acid / antagonists & inhibitors*
  • Brain / drug effects*
  • Brain / metabolism
  • Deferoxamine / pharmacology
  • Iron Chelating Agents / pharmacology
  • Lipid Peroxidation / drug effects*
  • Male
  • Quinolinic Acid / pharmacology*
  • Rats
  • Rats, Wistar
  • Siderophores / pharmacology

Substances

  • Iron Chelating Agents
  • Siderophores
  • Quinolinic Acid
  • Deferoxamine
  • Ascorbic Acid